Bizarre Patents
A vest or belt is integrally formed with tubular, pet receiving passageways which extend around the wearer's body and terminate in pocket-like chambers for feeding and retrieval.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8182849 | Fermented tea beverage and tea beverage The present invention provides a tea-based fermentation beverage comprising a tea-based fermentation liquid with at least one species of lactic acid bacteria selected from the group consisting of Lactobacillus ONRIC b0239 (FERM BP-10064) and Lactobacillus ... | 05/22/2012 |
| 8163753 | 2,3-dihydro-6-nitroimidazo (2,1-b) oxazole compounds for the treatment of tuberculosis The present invention provides a 2,3-dihydro-6-nitroimidazo[2,1-b]oxazole compound represented by the following general formula: (1) in the above formula (1), R1 represents a hydrogen atom or C1-C6 alkyl group, n represents an integer of 0 to 6, R1 and —(CH2)nR2 m... | 04/24/2012 |
| 8129544 | 1-substituted-4-nitroimidazole compound and method for preparing the same The present invention relates to a 1-substituted-4-nitroimidazole compound represented by the general formula (1) or a salt thereof, (wherein R is a hydrogen atom, a lower alkoxy group-substituted lower alkyl group, a pheny... | 03/06/2012 |
| 8093018 | Antibody identifying an antigen-bound antibody and an antigen-unbound antibody, and method for preparing the same The present invention relates to an antibody that recognizes a first antibody, the antibody specifically recognizing one of a free first antibody and an antigen-binding first antibody. More specifically, the above antibody is a domino antibody that specifically reco... | 01/10/2012 |
| 8088744 | Cholestanol derivative for combined use The invention provides a cancer chemotherapeutic agent which has fewer side effects and excellent efficacy. The cancer chemotherapeutic agent of the invention includes a cholestanol derivative represented by formula (1): (w... | 01/03/2012 |
| 8084442 | N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors The present invention provides a pyrrolidine compound of General Formula (1) or a salt thereof, wherein R101 and R102 are each independently a phenyl group or a pyridyl group, the phenyl group or the p... | 12/27/2011 |
| 8071600 | Derivatives of 4-piperazin-1-yl-4-benzo[B]thiophene suitable for the treatment of CNS disorders A heterocyclic compound or a salt thereof represented by the formula (1): where R2 represents a hydrogen atom or a lower alkyl group; A represents a lower alkylene group or lower alkenylene group; and R1 represents an aromatic group or a hetero... | 12/06/2011 |
| 8048995 | Human skeletal muscle-specific ubiquitin-conjugating enzyme The present invention provides novel human genes, for example a novel human gene comprising a nucleotide sequence coding for the amino acid sequence shown under SEQ ID NO:1. The use of the genes makes it possible to detect the expression of the same in various tissu... | 11/01/2011 |
| 8034763 | Platelet aggregation inhibitor composition The invention provides a pharmaceutical composition comprising at least one polypeptide of the following (a) to (d): (a) a polypeptide comprising the amino acid sequence of SEQ ID NO:1; (b) a polypeptide comprising an amino acid sequence co... | 10/11/2011 |
| 8030313 | Controlled release sterile injectable aripiprazole formulation and method A controlled release sterile freeze-dried aripiprazole formulation is provided which is formed of aripiprazole of a desired mean particle size and a vehicle therefor, which upon constitution with water and intramuscular injection releases aripiprazole over a period ... | 10/04/2011 |
| 8030312 | 5-HT1A receptor subtype agonist The present invention relates to a method of treating a patient suffering from a disorder of the central nervous system associated with 5-HT1A receptor subtype, comprising as an active ingredient a carbostyril derivative or a salt thereof represented by t... | 10/04/2011 |
| 8030075 | Carrier composition for nucleic acid transport An object of the present invention is to provide a nucleic acid delivery carrier composition of low toxicity and high safety, the carrier composition, when used to administer a nucleic acid such as an siRNA into an animal-derived cell or organism, being capable of d... | 10/04/2011 |
| 8017615 | Low hygroscopic aripiprazole drug substance and processes for the preparation thereof The present invention provides low hygroscopic forms of aripiprazole and processes for the preparation thereof which will not convert to a hydrate or lose their original solubility even when a medicinal preparation containing the anhydrous aripiprazole crystals is s... | 09/13/2011 |
| 8017584 | GD3-mimetic peptides GD3-Mimetic peptides which contain an amino acid sequence represented by any of SEQ ID NOS: 1 to 4 or an amino acid sequence derived therefrom by substitution, deletion, addition, or insertion of one or more amino acid residues and attaining specific binding to an a... | 09/13/2011 |
| 8007480 | Delivery device, delivery container, and eye dropper provided with the same The present invention has an object to provide a delivery device that is capable of preventing a content liquid from flowing back and achieving aseptic delivery of liquid drop (dripping), and provide a delivery container, and an eye dropper that can eliminate or red... | 08/30/2011 |
| 7994153 | Chloasma amelioration composition and dullness amelioration composition The present invention provides a composition that can effectively improve melasma and a composition that can effectively reduce skin dullness. The composition for improving melasma comprises a purine nucleic acid-related substance and a pharmaceutically or co... | 08/09/2011 |
| 7989446 | 4-amino 5-cyanopyrimidine derivatives The present invention provides 4-amino-5-cyanopyrimidine derivatives of the formula: wherein R1, R2 and R3 are defined herein, or pharmaceutically acceptable salts thereof, having a safe and potent adenosine A2a receptor agonistic ac... | 08/02/2011 |
| 7968116 | Antitumor agent A sugar-cholestanol compound which can be readily synthesized and which exhibits a satisfactory antitumor activity. An anticancer agent containing, as an active ingredient, a cholestanol compound represented by the following formula (1): | 06/28/2011 |
| 7964367 | Human p51 genes and gene products thereof Novel human genes falling within the category of family genes relating to p53 gene which is known as a cell proliferation regulatory gene, and gene products thereof. A human p51 gene characterized by containing a base sequence encoding an amino acid sequence represe... | 06/21/2011 |
| 7943623 | Pharmaceutical composition comprising 2,3-dihydro-6-nitroimidazo [2,1-B] oxazole derivatives A pharmaceutical composition according to the present invention comprises: (I) at least one member selected from the group consisting of oxazole compounds, optically active isomers thereof, and salts thereof, the oxazole compounds being represented by general formul... | 05/17/2011 |
| 7939060 | Isoflavone-containing composition This invention provides a composition comprising a daidzein-containing substrate and a strain of micro-organism capable of metabolizing daidzein to equol as essential ingredients. This composition is effective in the prevention and alleviation of unidentified clinic... | 05/10/2011 |
| 7932276 | Agent for curing chronic obstructive pulmonary disease The present invention provides a useful and highly safe agent for the treatment of chronic obstructive pulmonary disease, which contains, as the effective ingredient, at least one compound selected from the group consisting of thiazole derivatives and salts thereof ... | 04/26/2011 |
| 7931894 | Method of three-dimensionally culturing chondrocytes It is intended to provide a method of three-dimensionally culturing normal joint chondrocytes; the production and supply of chondrocytes; and a transplantation material to be used in an injured site in a joint tissue. ... | 04/26/2011 |
| 7927628 | Sustained release preparations and process for producing the same The present invention provides sustained-release preparations from which a pharmacologically active substance can be released over a long time and a process for producing the same. Such a sustained-release preparation is produced by melt-granulating a low-melting-po... | 04/19/2011 |
| 7910589 | Low hygroscopic aripiprazole drug substance and processes for the preparation thereof The present invention provides low hygroscopic forms of aripiprazole and processes for the preparation thereof which will not convert to a hydrate or lose their original solubility even when a medicinal preparation containing the anhydrous aripiprazole crystals is s... | 03/22/2011 |
| 7888362 | Piperazine-substituted benzothiophenes for treatment of mental disorders The present invention provides a heterocyclic compound represented by the general formula (1): The compound of the present invention has a wide treatment spectrum for mental disorders including central nervous system disorders, no side effects and high safety. | 02/15/2011 |
| 7846651 | Epitope/peptide recognized by HLA-A2402-restricted Ep-CAM-specific CTL and use of the same A peptide consisting essentially of the amino acid sequence represented by SEQ ID NO:1; a peptide consisting essentially of the amino acid sequence represented by SEQ ID NO:2; or a mutant peptide consisting essentially of an amino acid sequence derived from the amin... | 12/07/2010 |
| 7868207 | Process for producing 1-(3,4-dichlorobenzyl)-5-octylbiguanide or a salt thereof The present invention provides a process for producing 1-(3,4-dichlorobenzyl)-5-octylbiguanide or a salt thereof, the process comprising reacting 1-cyano-3-octylguanidine or a salt thereof, with 3,4-dichlorobenzylamine or a salt thereof, in an ester-based organic so... | 01/11/2011 |
| 7867514 | Method for stabilizing preparation Disclosed is a method for stabilizing a solid pharmaceutical preparation containing a pharmacological substance and sodium lauryl sulfate, the method comprising incorporating into the preparation at least one member selected from the group consisting of neutral salt... | 01/11/2011 |
| 7858754 | Nel-related protein type 1 antibody The present invention provides novel human genes, for example a novel human gene comprising a nucleotide sequence coding for the amino acid sequence shown under SEQ ID NO:1. The use of the genes makes it possible to detect the expression of the same in various tissu... | 12/28/2010 |
| 7851589 | Polypeptide derived from the ryanodine receptor that inhibits calcium leakage A polypeptide exhibiting the effect of inhibiting Ca2+ leakage in a target cell, the polypeptide having the amino acid sequence of any of SEQ ID NOs: 3 to 9 or an amino acid sequence obtained through deletion, insertion, substitution, or addition of one o... | 12/14/2010 |
| 7842495 | Lactic acid bacteria capable of stimulating mucosal immunity The invention provides lactic acid bacteria selected from the group consisting of lactobacillus ONRIC b0239 (FERM BP-10064) and lactobacillus ONRIC b0240 (FERM BP-10065), and compositions containing the bacteria, the compositions being capable of stimu... | 11/30/2010 |
| 7838229 | Identification marker responsive to interferon therapy for renal cell cancer The present invention provides an identification marker responsive to IFN therapy for renal cell cancer and a means of detecting the same. Namely, a method which comprises preparing a genomic DNA of a human gene or a complementary strand thereof from a specimen of a... | 11/23/2010 |
| 7834002 | 4-amino-5-cyanopyrimidine derivatives The present invention provides 4-amino-5-cyanopyrimidine derivatives of the formula: wherein R1, R2 and R3 are defined herein, or pharmaceutically acceptable salts thereof, having a safe and potent adenosine A2a receptor agonistic ac... | 11/16/2010 |
| 7833792 | Test strip measuring method In a test strip measuring method in which a coloration measurement is conducted while a test strip (4) is being moved, there are detected the optical characteristics R of the ground of a test strip and the optical characteristics T of a test line (4... | 11/16/2010 |
| 7829518 | Aqueous solution of olanexidine, method of preparing the aqueous solution, and disinfectant The present invention provides a disinfectant that contains olanexidine in a concentration sufficient to exhibit an effective bactericidal effect, and that has hardly any side effects such as skin irritation. Specifically, the present invention provides a disinfecta... | 11/09/2010 |
| 7825251 | Process for producing carbostyril derivatives The present invention provides a process for producing carbostyril derivatives (I) which are known to be useful as medical drug such as antithrombotic agent, cerebral circulation improver, anti-inflammatory agent, antiulcer agent, etc. in a high yield and a high pur... | 11/02/2010 |
| 7825130 | PTEN inhibitor or Maxi-K channels opener A new PTEN opener or a new opener of a large conductance Ca2+-activated K+ channel (Maxi-K channel) which comprises as an active ingredient a tetrazolylalkoxy-dihydrocarbostyril compound of the formula (I): ... | 11/02/2010 |
| 7825080 | Aqueous solution of olanexidine, method of preparing the aqueous solution, and disinfectant The present invention provides a disinfectant that contains olanexidine in a concentration sufficient to exhibit an effective bactericidal effect, and that has hardly any side effects such as skin irritation. Specifically, the present invention provides a disinfecta... | 11/02/2010 |
| 7820636 | Sugar intake promoters An object of the invention is to provide a substance that activates saccharide uptake in epidermal cells and is thus expected to be effective in promoting skin cell neogenesis and metabolism. The invention provides a promoter for saccharide uptake in epidermal kerat... | 10/26/2010 |
